| MMPs | matrix metalloproteinase |
| DOX | doxorubicin |
| TPGS3350 | D-α-tocopherol polyethylene glycol 3350 succinate |
| GPLGVRGDG | Gly-Pro-Leu-Gly-Val-Arg-Gly-Asp-Gly |
| GPLGVRG | Gly-Pro-Leu-Gly-Val-Arg-Gly |
| VRGDG | Val-Arg-Gly-Asp-Gly |
| PEG | polyethylene glycol |
| EPR | enhanced permeability and retention |
| FDA | US Food and Drug Administration |
| MMP | matrix metalloproteinase |
| HLB | hydrophilic/lipophilic balance |
| CMC | critical micelle concentration |
| RGD | Arg-Gly-Asp |
| PBS | Phosphate-Buffered Saline |
| P1 | TPGS3350-GPLGVRGDG-DOX & DOX |
| P2 | TPGS3350-GPLGVRG-DOX & DOX |
| P3 | TPGS3350-DOX & DOX |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.